TML-6

Item no.	TMO-T37148-100mg
Manufacturer	TargetMol
CASRN	1462868-88-7
Amount	100 mg
Quantity options	100 mg 100 mg 10 mg 25 mg 25 mg 50 mg 50 mg 5 mg
Category	Oncology By Cell Type Carcinoma Hematology Leukemia Lymphoma Myeloma Melanoma Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Smiles	CCN(CC)C(=O)CC(C)(C(=O)\C=C\c1ccc(OC)c(OC)c1)C(=O)\C=C\c1ccc(OC)c(OC)c1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Others\|\|\|Nrf2\|\|\|mTOR\|\|\|Beta Amyloid\|\|\|NF-κB
Shipping Temperature	Cool pack
Storage Conditions	-20°C
Molecular Weight	523, 62
Description	TML-6, an oral curcumin derivative, demonstrates inhibitory effects on the synthesis of β-amyloid precursor protein and β-amyloid (Aβ). Additionally, TML-6 exhibits upregulation of Apo E, suppression of NF-κB and mTOR, and enhancement of the anti-oxidative Nrf2 gene activity. Considering its diverse pharmacological profile, TML-6 holds promise as a valuable research tool for investigating Alzheimer's disease (AD)[1].
Pathways	NF-κB\|\|\|Immunology/Inflammation\|\|\|PI3K/Akt/mTOR signaling\|\|\|Neuroscience\|\|\|Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T37148-100mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question